Robert Olstein's MDT Position Overview
Robert Olstein (via Olstein Capital Management, L.P.) currently holds 87,000 shares of Medtronic plc (MDT) worth $8.29 M, representing 1.56% of the portfolio. First purchased in 2015-Q1, this long-term strategic position has been held for 43 quarters.
Based on 13F filings since 2013, Robert Olstein has maintained a long-term strategic position in MDT, representing a significant commitment to this investment thesis. Largest addition occurred in Q4 2016, adding 61,568 shares. Largest reduction occurred in Q2 2016, reducing 30,000 shares.
Analysis based on 13F filings available since 2013 Q2
Robert Olstein's Medtronic plc (MDT) Holding Value Over Time
Track share changes against reported price movement
Quarterly Medtronic plc (MDT) Trades by Robert Olstein
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2015 | +134,000 | New Buy | 134,000 | $77.99 |
| Q4 2015 | -26,000 | Reduce 19.40% | 108,000 | $76.92 |
| Q1 2016 | -12,000 | Reduce 11.11% | 96,000 | $75.00 |
| Q2 2016 | -30,000 | Reduce 31.25% | 66,000 | $86.77 |
| Q3 2016 | -17,568 | Reduce 26.62% | 48,432 | $86.41 |
| Q4 2016 | +61,568 | Add 127.12% | 110,000 | $71.23 |
| Q1 2017 | +11,000 | Add 10.00% | 121,000 | $80.56 |
| Q2 2017 | -29,850 | Reduce 24.67% | 91,150 | $88.75 |
| Q3 2017 | +19,850 | Add 21.78% | 111,000 | $77.77 |
| Q4 2017 | +6,000 | Add 5.41% | 117,000 | $80.75 |
| Q1 2018 | -1,000 | Reduce 0.85% | 116,000 | $80.22 |
| Q2 2018 | -30,000 | Reduce 25.86% | 86,000 | $85.60 |
| Q3 2018 | -15,080 | Reduce 17.53% | 70,920 | $98.36 |
| Q4 2018 | -8,920 | Reduce 12.58% | 62,000 | $90.97 |
| Q1 2019 | +7,000 | Add 11.29% | 69,000 | $91.09 |
| Q2 2019 | +5,000 | Add 7.25% | 74,000 | $97.39 |
| Q4 2019 | -5,000 | Reduce 6.76% | 69,000 | $113.45 |
| Q1 2020 | +2,000 | Add 2.90% | 71,000 | $90.18 |
| Q2 2020 | +15,000 | Add 21.13% | 86,000 | $91.70 |
| Q4 2020 | -10,000 | Reduce 11.63% | 76,000 | $117.14 |
| Q2 2021 | -5,000 | Reduce 6.58% | 71,000 | $124.13 |
| Q3 2021 | -3,000 | Reduce 4.23% | 68,000 | $125.35 |
| Q4 2021 | +38,000 | Add 55.88% | 106,000 | $103.45 |
| Q1 2022 | -5,000 | Reduce 4.72% | 101,000 | $110.95 |
| Q2 2022 | -24,000 | Reduce 23.76% | 77,000 | $89.75 |
| Q4 2022 | +23,000 | Add 29.87% | 100,000 | $77.72 |
| Q4 2023 | +2,000 | Add 2.00% | 102,000 | $82.38 |
| Q2 2024 | -29,000 | Reduce 28.43% | 73,000 | $78.71 |
| Q3 2024 | +14,000 | Add 19.18% | 87,000 | $90.03 |
| Q4 2024 | +7,000 | Add 8.05% | 94,000 | $79.88 |
| Q1 2025 | -10,000 | Reduce 10.64% | 84,000 | $89.86 |
| Q3 2025 | +3,000 | Add 3.57% | 87,000 | $95.24 |
Robert Olstein's Medtronic plc Investment FAQs
Robert Olstein first purchased Medtronic plc (MDT) in Q1 2015, acquiring 134,000 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Robert Olstein has held Medtronic plc (MDT) for 43 quarters since Q1 2015. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Robert Olstein's largest addition to Medtronic plc (MDT) was in Q1 2015, adding 134,000 shares worth $10.45 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Robert Olstein's firm, Olstein Capital Management, L.P., owns 87,000 shares of Medtronic plc (MDT), valued at approximately $8.29 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, Medtronic plc (MDT) represents approximately 1.56% of Robert Olstein's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Robert Olstein's peak holding in Medtronic plc (MDT) was 134,000 shares, as reported at the end of Q1 2015. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.